Study guide

15.7 Viruses: HIV & Human Herpesvirus

PA-CAT Physician Assistant College Admission Test

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 PA-CAT Exam Facts & Overview 1.2 Exam Structure & the Nine-Subject Blueprint 1.3 Registration, Scheduling & Test Day 1.4 Scoring, Transcripts & Study Strategy

2 Chapter 2: Anatomy — Back & Abdomen

2.1 Curvatures of the Vertebral Column 2.2 The Vertebrae 2.3 Spinal Cord and Spinal Nerves 2.4 The Anterior Abdominal Wall 2.5 The Spleen, Esophagus & Stomach 2.6 Intestines, Pancreas, Liver, Biliary Ducts, Hepatic Circulation & Kidney/Ureters

3 Chapter 3: Anatomy — Head, Pelvis & Perineum

3.1 The Skull 3.2 The Face & The Ear 3.3 The Cranial Nerves 3.4 The Bony Pelvis 3.5 The Pelvic Viscera 3.6 Male & Female Perineum and Reproductive Organs

4 Chapter 4: Anatomy — Thorax & Limbs

4.1 Mediastinum & Thoracic Skeletal/Muscular Components 4.2 Lungs, Trachea, Bronchi & Pericardium 4.3 The Heart & Great Vessels 4.4 Pectoral Girdle, Axilla & Brachial Plexus 4.5 Arm, Forearm, Wrist & Hand 4.6 Hip, Thigh, Gluteal Region, Leg, Joints & Foot

5 Chapter 5: Physiology — Cell, Blood & Circulation

5.1 Functions of the Cellular Organelles 5.2 Translation & Transcription 5.3 Hemostasis & Blood Coagulation 5.4 Basics of Flow, Pressure & Resistance 5.5 Microcirculation & Mechanisms of Blood Flow Control 5.6 Cardiac Output, Venous Return & the Lymphatic System 5.7 Coronary Blood Flow

6 Chapter 6: Physiology — Endocrine, GI & Membrane

6.1 Hypothalamus & Pituitary Hormones 6.2 Thyroid & Parathyroid Hormones 6.3 Endocrine & Adrenocortical Hormones 6.4 GI Motility, Secretion, Digestion & Absorption 6.5 Diffusion, Osmosis & Membrane Transport 6.6 Membrane Potential & the Action Potential 6.7 Muscular Contraction & Carbohydrate/Protein/Lipid Metabolism

7 Chapter 7: Physiology — Nervous & Renal

7.1 Nerve Physiology, Conduction & Transmission 7.2 Somatic Sensations, Motor/Cerebral Circuits & the Autonomic Nervous System 7.3 Fluid Balance, Glomerular Filtration & Tubular Reabsorption/Secretion 7.4 Renal Ion & Acid-Base Regulation

8 Chapter 8: Physiology — Respiratory, Reproduction, Heart & Senses

8.1 Pulmonary Ventilation, Gas Exchange & Pulmonary Circulation/Edema 8.2 O2/CO2 Transport & Regulation of Respiration 8.3 Reproduction: Mitosis/Meiosis, Gametogenesis, Pregnancy & Fetal Physiology 8.4 Heart Structure, Cardiac Cycle, Electrical Activity, Heart Defects & Special Senses

9 Chapter 9: Chemistry — Acids, Atoms, Bonding & Gases

9.1 Brønsted-Lowry Acids/Bases, Measuring Acidity & Strengths 9.2 Atomic Theory, Ions & Molecules 9.3 Chemical Bonding & VSEPR Molecular Geometry 9.4 Balancing, Solubility Rules & Types of Reactions 9.5 Oxidation, Reduction & Electrochemistry 9.6 Gas Laws, Dalton's Partial Pressures & Ideal vs Real Gases

10 Chapter 10: Chemistry — Liquids, Stoichiometry, Thermochemistry & Organic I

10.1 Colligative Properties & Factors Affecting Solubility 10.2 Stoichiometry: Conservation of Matter/Energy & Reactant/Product Calculations 10.3 Thermochemistry & Energy in Chemical Changes 10.4 Alkanes & Cycloalkanes 10.5 Bond Properties & Resonance 10.6 Hybridization/LCAO & Stereochemistry

11 Chapter 11: Chemistry — Spectroscopy & Application

11.1 Spectroscopy 11.2 Acid-Base Titrations & Buffer Systems 11.3 Limiting-Reactant & Percent-Yield Calculations 11.4 Electrochemical Cells & Redox Applications 11.5 Organic Reactions & Functional-Group Reactivity 11.6 Spectroscopic Structure Determination

12 Chapter 12: General Biology — Bioenergetics, Cells & Respiration

12.1 Enzymes, Metabolism, Energy & ATP 12.2 Hydrogen/Electron Carriers & Thermodynamics/Free Energy 12.3 Genome Mapping, Characterizing & Sequencing (Biotechnology) 12.4 Cell Structures, Membranous Organelles & Cell Theory 12.5 Eukaryotic Cell Reproduction & Stages of Meiosis 12.6 Cellular Respiration & Fermentation

13 Chapter 13: General Biology — Transport, Building Blocks & Molecules

13.1 Diffusion/Osmosis, Facilitated & Active Transport, Pinocytosis/Phagocytosis 13.2 Chemical Building Blocks: Proteins, Carbohydrates, Carbon, Nucleic Acids & Lipids 13.3 Water, Organization of Matter & Acids/Bases/Salts 13.4 Biological Molecules: DNA Structure, Replication & Repair 13.5 Gene Expression: Regulation, RNA & Protein Degradation

14 Chapter 14: General Biology — RNA, Structure & Signaling

14.1 Types of RNA, tRNA & Ribosomes 14.2 Pre-mRNA Splicing & Eukaryotic Transcription 14.3 Signal Transduction & Intracellular Communication 14.4 Receptor Types & Intracellular Receptors 14.5 G Protein-Coupled Receptor & Receptor Kinase Signaling

15 Chapter 15: Microbiology — Bacteria

15.1 Intracellular Bacteria 15.2 Gram-Positive Cocci & Rods 15.3 Acid-Fast Bacteria 15.4 Gram-Negative Cocci/Coccobacilli & Fermentative/Nonfermenting Rods 15.5 Anaerobic & Spiral-Shaped Bacteria 15.6 Bacterial Role in Disease 15.7 Viruses: HIV & Human Herpesvirus

16 Chapter 16: Microbiology — Viruses, Fungi, Parasites & Host Interaction

16.1 Respiratory, Hepatitis & Gastrointestinal Viruses + Viral Role in Disease 16.2 Fungal Classification, Opportunistic & Cutaneous/Subcutaneous Fungi 16.3 Systemic Dimorphic Fungi 16.4 Parasites: Protozoa & Helminths (Trematodes, Nematodes, Cestodes) 16.5 Parasite Classification & Arthropods 16.6 Principles of Disease, Epidemiology & Microbial Pathogenicity 16.7 Innate/Adaptive Immunity, Pathology/Infection/Disease, Microorganisms & Human Disease, Environmental Microbiology

17 Chapter 17: Genetics — Molecular Structure & Patterns of Inheritance

17.1 Molecular Structure of DNA & RNA 17.2 Chromosome Organization & DNA Replication 17.3 Chromosome Transmission During Cell Division & Sexual Reproduction 17.4 Mendelian & Non-Mendelian Inheritance 17.5 Genetic Linkage & Mapping in Eukaryotes 17.6 Genetic Transfer & Mapping in Bacteria and Bacteriophages

18 Chapter 18: Genetics — Genes, Mutation, Technologies & Medical Genetics

18.1 Molecular Properties of Genes & the Central Dogma 18.2 Mutation: Types & Consequences 18.3 Recombinant DNA & Genetic Technologies 18.4 Gene Regulation in Prokaryotes & Eukaryotes 18.5 Medical Genetics: Mendelian/Chromosomal/Multifactorial Disorders & Screening 18.6 Cancer Genetics 18.7 Population, Developmental & Quantitative Genetics

19 Chapter 19: Behavioral Sciences — Biological Bases of Behavior & Psychology

19.1 Behavioral Neuroscience: Neuroanatomy & Function 19.2 Sensation & Movement 19.3 States of Consciousness 19.4 Learning & Memory 19.5 Cognition, Language & Intelligence 19.6 Psychology: Schools, Development & Personality

20 Chapter 20: Behavioral Sciences — Stress, Research Methods, Sociocultural & Psychological Disorders

20.1 Health, Stress & Coping 20.2 Psychological Research Methods 20.3 Sociocultural Identity & Development 20.4 Psychological Disorders 20.5 Treatment of Psychological Disorders 20.6 Applied & Lifespan Behavioral Science

21 Chapter 21: Biochemistry — Metabolism, Enzymes & Proteins

21.1 Enzymes: Kinetics & Regulation 21.2 Carbohydrate Metabolism 21.3 TCA Cycle, Electron Transport & Oxidative Phosphorylation 21.4 Lipid Metabolism 21.5 Amino Acid & Nitrogen Metabolism + Protein Structure

22 Chapter 22: Biochemistry — Nucleic Acids, Hormones & Lipids

22.1 Nucleic Acids & Nucleotide Biochemistry 22.2 Hormone Biochemistry & Second-Messenger Systems 22.3 Vitamins & Minerals 22.4 Lipid Structure, Membranes & Transport 22.5 Tissue-Specific Biochemistry & Metabolic Integration

23 Chapter 23: Statistics — Anticipating Patterns & Exploring Data

23.1 Exploring & Describing Data 23.2 Probability 23.3 Random Variables & Probability Distributions 23.4 Sampling Distributions & Simulations

24 Chapter 24: Statistics — Sampling, Experimentation & Statistical Inference

24.1 Sampling, Experimentation & Data Collection 24.2 Confidence Intervals 24.3 Hypothesis Testing 24.4 Inference for Comparisons, Chi-Square & Regression

15.7 Viruses: HIV & Human Herpesvirus

Key Takeaways Explain This Topic AI

HIV is an enveloped (+)ssRNA retrovirus with two copies of genomic RNA, reverse transcriptase, integrase, and protease; it binds CD4 plus CCR5 (M-tropic) or CXCR4 (T-tropic) co-receptors

Reverse transcriptase copies viral RNA into dsDNA, which integrase inserts into the host genome as a provirus; this latent integrated form is the barrier to cure

CD4 count thresholds define AIDS (<200 cells/μL) and opportunistic infection risk; prophylaxis for PCP begins below 200 and for MAC below 50

The eight human herpesviruses all establish latency and cause recurrent disease: HSV-1/2 (oral/genital), VZV (chickenpox/shingles), EBV (mononucleosis, Burkitt lymphoma), CMV (retinitis, congenital), HHV-6 (roseola), HHV-8 (Kaposi sarcoma)

Antiretroviral therapy combines two NRTIs with an integrase inhibitor (first-line) and suppresses viral load to undetectable, restoring CD4 counts and preventing transmission (U=U)

Last updated: August 2026

Human Immunodeficiency Virus (HIV)

HIV is the cause of acquired immunodeficiency syndrome (AIDS) . Two types exist: HIV-1 (global pandemic, more virulent) and HIV-2 (West Africa, slower course). The PA-CAT Bulletin of Information, rev. 20240815, places HIV within the Viruses group of the Microbiology blueprint. Understanding HIV structure and lifecycle is the foundation for both pathology questions and antiretroviral pharmacology.

Structure

HIV is an enveloped (+)ssRNA retrovirus with a diploid genome — two identical copies of ~9.7 kb RNA — packaged with three key enzymes:

Reverse transcriptase (RT) — RNA-dependent DNA polymerase (lacks proofreading, hence high mutation rate).

Integrase — inserts viral dsDNA into host chromosomes.

Protease — cleaves polyproteins (Gag-Pol) into mature virion components.

The envelope contains gp120 (surface, binds receptor) and gp41 (transmembrane, mediates fusion), derived by cleavage of gp160 by host furin. The matrix protein (p17) lines the inner envelope; the capsid (p24, the major core antigen detected in fourth-generation tests) encases the RNA–enzyme complex.

Receptors and Cell Tropism

HIV binds CD4 on helper T cells, macrophages, and dendritic cells, then engages a co-receptor :

CCR5 — used by M-tropic (R5) strains, dominant early in infection and in mucosal transmission. People homozygous for the CCR5-Δ32 deletion are largely resistant to HIV infection.

CXCR4 — used by T-tropic (X4) strains, often emerging later and associated with rapid CD4 decline.

A key clinical corollary: maraviroc is a CCR5 antagonist effective only against R5-tropic virus (requires tropism testing).

HIV Replication Lifecycle

Attachment — gp120 binds CD4, conformational change exposes co-receptor binding site.

Co-receptor binding (CCR5 or CXCR4) triggers gp41 fusion.

Fusion and entry — viral core is released into cytoplasm.

Uncoating — capsid disassembles, releasing RNA–enzyme complex.

Reverse transcription — RT synthesizes a complementary DNA strand, degrades RNA (RNase H), and synthesizes the second DNA strand, producing dsDNA .

Nuclear import — the pre-integration complex enters the nucleus (HIV can infect non-dividing cells because integrase and matrix contain nuclear localization signals).

Integration — integrase cuts host DNA and ligates viral dsDNA, forming the provirus . This integrated form is the barrier to cure because it persists in latent reservoirs.

Transcription and splicing — host RNA polymerase II transcribes viral RNA; Rev protein exports unspliced and singly spliced RNAs.

Translation — Gag and Gag-Pol polyproteins (from unspliced RNA), Env (from spliced mRNA).

Assembly — virions bud from the plasma membrane.

Maturation — protease cleaves Gag-Pol into functional proteins; immature non-infectious particles become infectious. Protease inhibitors block this step.

Diagnosis

Modern algorithms start with a fourth-generation antigen/antibody combination assay (detects p24 antigen and anti-HIV-1/2 antibodies), narrowing the window period to ~18–45 days. Reactive results are confirmed with an HIV-1/HIV-2 differentiation immunoassay . Nucleic acid tests (HIV RNA) diagnose acute infection before seroconversion and quantify viral load for monitoring.

Stages of HIV Infection

Stage Description Typical CD4

Acute (retroviral) syndrome 2–4 weeks post-exposure; mononucleosis-like illness (fever, lymphadenopathy, rash, oral ulcers), high viremia Transient dip

  • Clinical latency (chronic) Asymptomatic or mild symptoms; CD4 slowly declines; viral load set point >500 → 200
  • AIDS Opportunistic infections, malignancies, wasting <200 cells/μL
  • AIDS-Defining Opportunistic Infections
  • CD4 threshold Risk
  • <500 Candida thrush, tuberculosis
  • <200 Pneumocystis jirovecii pneumonia (PCP) — prophylaxis with TMP-SMX; reactivation VZV , HSV
  • <100 Toxoplasma gondii encephalitis (ring-enhancing lesions); Cryptococcus neoformans meningitis

<50 Mycobacterium avium-complex (MAC) disseminated; CMV retinitis; progressive multifocal leukoencephalopathy (JC virus)

AIDS-defining malignancies include Kaposi sarcoma (HHV-8) , primary CNS lymphoma and systemic non-Hodgkin lymphoma (EBV-related) , and invasive cervical carcinoma (HPV) .

Antiretroviral Therapy (ART)

First-line ART combines two NRTIs (tenofovir + emtricitabine, or abacavir + lamivudine) with an integrase strand-transfer inhibitor (INSTI) — dolutegravir, bictegravir, or raltegravir. Drug classes target each lifecycle step:

  • Class Example Target
  • NRTI Tenofovir, emtricitabine, zidovudine Reverse transcriptase (nucleoside analog)
  • NNRTI Efavirenz, nevirapine, rilpivirine Reverse transcriptase (non-nucleoside allosteric)
  • INSTI Dolutegravir, bictegravir, raltegravir Integrase
  • PI Darunavir, atazanavir (ritonavir-boosted) Protease
  • Entry inhibitor Enfuvirtide (fusion), maraviroc (CCR5) gp41; CCR5

ART suppresses viral load to undetectable (<200 copies/mL), restores CD4 counts, prevents transmission ( U=U ), and prevents drug resistance when adherence is high. Pre-exposure prophylaxis (PrEP) with tenofovir/emtricitabine reduces sexual acquisition by ~99%.

Human Herpesviruses

The Herpesviridae are enveloped, dsDNA viruses with an icosahedral capsid and a tegument layer. A defining property is latency : after primary infection, viral genomes persist in neurons (HSV-1/2, VZV) or B cells/monocytes (EBV, CMV, HHV-6/7) and reactivate under stress, immunosuppression, or UV light. Eight human herpesviruses are recognized:

  • HHV # Virus Latency site Classic disease
  • HHV-1 HSV-1 Trigeminal ganglia Oral-labial herpes (cold sores); increasingly genital
  • HHV-2 HSV-2 Sacral ganglia Genital herpes
  • HHV-3 VZV (varicella-zoster) Dorsal root ganglia Chickenpox (primary), shingles (reactivation)

HHV-4 EBV (Epstein-Barr) B lymphocytes Infectious mononucleosis; Burkitt lymphoma; nasopharyngeal carcinoma; Hodgkin lymphoma

HHV-5 CMV (cytomegalovirus) Monocytes, endothelium Mononucleosis (negative heterophile); retinitis in AIDS; congenital CMV

  • HHV-6 HHV-6A/B T lymphocytes Roseola infantum (exanthem subitum) in infants; febrile seizures
  • HHV-7 HHV-7 T lymphocytes Pityriasis rosea (association)

HHV-8 HHV-8 (KSHV) Endothelial, B cells Kaposi sarcoma , primary effusion lymphoma, multicentric Castleman disease

HSV-1 and HSV-2

Herpes simplex viruses produce vesicular lesions on an erythematous base. Primary infection is usually more severe than reactivation. HSV-1 classically causes orolabial lesions ('cold sores') and increasingly genital herpes; HSV-2 predominantly causes genital herpes. Reactivation triggers include UV light, fever, stress, and menstruation. Genital HSV can be transmitted even without visible lesions (asymptomatic shedding).

Diagnosis: PCR of lesion swab (gold standard) or CSF (HSV encephalitis — temporal lobe predilection); Tzanck smear shows multinucleated giant cells with eosinophilic intranuclear inclusions (Cowdry type A) but is less sensitive. Treatment: acyclovir, valacyclovir, or famciclovir ; suppressive therapy reduces recurrences and transmission. Acyclovir requires viral thymidine kinase to phosphorylate it to the active form, so it has minimal host toxicity but is inactive against CMV (which lacks TK).

VZV — Chickenpox and Shingles

Primary VZV causes varicella (chickenpox) : fever and a pruritic vesicular rash in crops that progresses from macules → papules → vesicles → pustules → crusts, starting on the trunk and spreading peripherally. The virus then establishes latency in dorsal root ganglia . Reactivation produces herpes zoster (shingles) : a painful vesicular eruption in a single dermatome (thoracic and lumbar most common; ophthalmic branch of V1 in herpes zoster ophthalmicus). Post-herpetic neuralgia is the most common complication.

The varicella vaccine (live attenuated) prevents primary disease; the shingles vaccine (recombinant zoster vaccine, RZV) prevents reactivation and post-herpetic neuralgia, recommended for adults ≥50. Antivirals (acyclovir, valacyclovir, famciclovir) are most effective when started within 72 hours of rash onset.

EBV — Infectious Mononucleosis

EBV infects B cells via CD21 (CR2) and establishes latency. Infectious mononucleosis presents with fever, exudative pharyngitis, lymphadenopathy (especially posterior cervical), and fatigue , often with splenomegaly (avoid contact sports to prevent splenic rupture). Atypical Downey lymphocytes on smear are reactive cytotoxic T cells, not EBV-infected B cells.

Heterophile antibody (Monospot) agglutinates horse/sheep RBCs; it is positive in ~90% of adults but less sensitive in young children. EBV-specific serology (VCA IgM, EBNA IgG) clarifies ambiguous cases. EBV is also associated with African Burkitt lymphoma (t(8;14) c-myc translocation), nasopharyngeal carcinoma , Hodgkin lymphoma, and post-transplant lymphoproliferative disorder (PTLD).

CMV

CMV causes the 'CMV mononucleosis' syndrome that is heterophile-negative and often presents with fever and mild hepatitis ; petechial rash may follow ampicillin administration (similar to EBV). In immunocompromised hosts, CMV causes retinitis (AIDS with CD4 <50 — 'pizza-pie' fundus), colitis with ulceration, esophagitis , pneumonitis (transplant recipients), and encephalitis . Congenital CMV is the most common congenital infection in the U.S. — sensorineural hearing loss , petechiae ('blueberry muffin' rash from dermal extramedullary hematopoiesis), chorioretinitis, and periventricular calcifications.

Treatment: ganciclovir, valganciclovir, foscarnet, or cidofovir (not acyclovir — CMV lacks TK; ganciclovir is phosphorylated by the UL97 kinase ). Letermovir (CMV terminase inhibitor) is used for prophylaxis in stem-cell transplant recipients.

HHV-6 — Roseola Infantum

HHV-6B causes roseola (exanthem subitum, sixth disease) : high fever for 3–5 days in an otherwise well-appearing infant, followed by defervescence and a maculopapular rash that appears as fever drops. Febrile seizures are a feared complication. The rash starts on the trunk and spreads to the face and extremities.

HHV-8 — Kaposi Sarcoma

HHV-8 (KSHV) is the causative agent of Kaposi sarcoma , an angioproliferative tumor classically seen in AIDS patients (especially MSM) but also in classic (Mediterranean/Eastern European elderly men), endemic (sub-Saharan Africa), and transplant-associated forms. Lesions are violaceous plaques and nodules on skin, oral mucosa, GI tract, and lungs.

HIV and Herpesviruses: Key Interactions

EBV-driven primary CNS lymphoma and HHV-8 Kaposi sarcoma are AIDS-defining malignancies.

CMV retinitis and chronic progressive VZV (zoster that disseminates) are classic late-stage opportunistic diseases.

HSV reactivation is common at any CD4 count but more severe with immunosuppression.

ART-induced immune reconstitution inflammatory syndrome (IRIS) can unmask occult herpesvirus disease (e.g., CMV retinitis, VZV uveitis) within weeks of starting therapy.

Loading diagram...

Approximate clinical importance weight among human herpesviruses (illustrative)